Global Immunoprotein Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

Global Immunoprotein Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state.

LPI (LP Information)' newest research report, the “Immunoprotein Diagnostic Testing Industry Forecast” looks at past sales and reviews total world Immunoprotein Diagnostic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunoprotein Diagnostic Testing sales for 2023 through 2029. With Immunoprotein Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoprotein Diagnostic Testing industry.

This Insight Report provides a comprehensive analysis of the global Immunoprotein Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunoprotein Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunoprotein Diagnostic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoprotein Diagnostic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoprotein Diagnostic Testing.

The global Immunoprotein Diagnostic Testing market size is projected to grow from US$ 15350 million in 2022 to US$ 23270 million in 2029; it is expected to grow at a CAGR of 6.1% from 2023 to 2029.

The increasing use of immunochromatography-based cassette kits or test strips is estimated to be one of the primary growth drivers for the global immunoprotein diagnostic testing market till 2023. Immunochromatography is the chromatographic method of immunoassay. It follows the lateral flow testing. It helps in the detection of infectious diseases, oncology, and autoimmune diseases using immunoproteins. The principle behind the working of immunochromatography is similar to the enzyme-linked immunosorbent assay (ELISA) test. These tests and reagents will improve the efficiency of diagnosis of diseases. Furthermore, several companies are investing heavily in research and developmental activities to develop products that reduce the time required to generate results.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunoprotein Diagnostic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Prealbumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others

Segmentation by application
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Beckman Coulter
DiaSorin
F. Hoffmann-La Roche
Siemens Healthineers

Please note: The report will take approximately 2 business days to prepare and deliver.